National Observatory of Atherosclerosis in Nephrology
To identify diagnostic tools capable of improving cardiovascular risk assessment in patients with chronic kidney disease (CKD) beyond traditional risk factors are currently warranted. Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
- Start Year
- End Year
- Study design
- Population cohort
Betriu A., Martinez-Alonso M., Arcidiacono M.V., Cannata-Andía J.B., Pascual J., Valdivielso J.M., Fernández E. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: The NEFRONA study. Nephrol. Dial. Transplant. 2014;29:1415–1422. doi: 10.1093/ndt/gfu038.
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Aged 18-75 years; Chronic Kidney Disease(CKD) stage 3 or higher, and no previous Cardiovascular events (CVE) .
Availability of data and biosamples
No coverage data about the variables classifications are available.